Melanoma Journal Articles for January 2020
BJD
Neoadjuvant immunotherapy with combined ipilimumab and nivolumab in patients with melanoma with primary or in transit disease
- WeberV. GlutschE. Geissinger L. Haug J.F. Lock F. Schneider H. Kneitz M. Goebeler B. Schilling A. Gesierich
First published: 26 November 2019 https://doi.org/10.1111/bjd.18739
Nature Communications
Siah2 control of T-regulatory cells limits anti-tumor immunity
Marzia Scortegagna, Kathryn Hockemeyer, Igor Dolgalev, Joanna Po?niak, Florian Rambow, Yan Li, Yongmei Feng, Roberto Tinoco, Dennis C. Otero, Tongwu Zhang, Kevin Brown, Marcus Bosenberg, Linda M. Bradley, Jean-Christophe Marine, Ioannis Aifantis & Ze’ev A. Ronai
Nature Communications volume 11, Article number: 99 (2020)
Cells
Dissecting Mechanisms of Melanoma Resistance to BRAF and MEK Inhibitors Revealed Genetic and Non-Genetic Patient- and Drug-Specific Alterations and Remarkable Phenotypic Plasticity
by Mariusz L. Hartman,Malgorzata Sztiller-Sikorska,Anna Gajos-Michniewicz andMalgorzata Czyz *
Cells 2020, 9(1), 142; https://doi.org/10.3390/cells9010142
Received: 29 November 2019 / Revised: 29 December 2019 / Accepted: 3 January 2020 / Published: 7 January 2020
JAMA
Ophthalmic Images
January 9, 2020
Choroidal Metastasis From Melanoma Treated by Cyberknife Irradiation
Thibaud Mathis, MD1; Jean-Pierre Caujolle, MD2; Juliette Thariat, MD, PhD3
JAMA Ophthalmol. 2020;138(1):e190388. doi:10.1001/jamaophthalmol.2019.0388
Clinical Science
The TERT copy number gain is sensitive to telomerase inhibitors in human melanoma
Jinyu Yu ; Jiayi Yu ; Xiaowen Wu ; Qian Guo ; Ting Yin ; Zhiyuan Cheng ; Jie Dai ; Yan Kong ; Jun Guo
Clin Sci (Lond) (2020) CS20190890.
https://doi.org/10.1042/CS20190890
JAMA
Original Investigation
November 13, 2019
Age-Specific Incidence of Melanoma in the United States
Kelly G. Paulson, MD, PhD1,2,3; Deepti Gupta, MD4,5,6; Teresa S. Kim, MD3,7; et alJoshua R. Veatch, MD, PhD1,2,3; David R. Byrd, MD3,7; Shailender Bhatia, MD1,2,3; Katherine Wojcik, PhD1; Aude G. Chapuis, MD1,2,3; John A. Thompson, MD1,2,3; Margaret M. Madeleine, PhD, MPH8,9; Jennifer M. Gardner, MD3,5
JAMA Dermatol. 2020;156(1):57-64. doi:10.1001/jamadermatol.2019.3353
Siah2 control of T-regulatory cells limits anti-tumor immunity
Marzia Scortegagna, Kathryn Hockemeyer, Igor Dolgalev, Joanna Po?niak, Florian Rambow, Yan Li, Yongmei Feng, Roberto Tinoco, Dennis C. Otero, Tongwu Zhang, Kevin Brown, Marcus Bosenberg, Linda M. Bradley, Jean-Christophe Marine, Ioannis Aifantis & Ze’ev A. Ronai
Nature Communications volume 11, Article number: 99 (2020)
Cells
Dissecting Mechanisms of Melanoma Resistance to BRAF and MEK Inhibitors Revealed Genetic and Non-Genetic Patient- and Drug-Specific Alterations and Remarkable Phenotypic Plasticity
by Mariusz L. Hartman,Malgorzata Sztiller-Sikorska,Anna Gajos-Michniewicz andMalgorzata Czyz *
Cells 2020, 9(1), 142; https://doi.org/10.3390/cells9010142
Received: 29 November 2019 / Revised: 29 December 2019 / Accepted: 3 January 2020 / Published: 7 January 2020
JAMA
Ophthalmic Images
January 9, 2020
Choroidal Metastasis From Melanoma Treated by Cyberknife Irradiation
Thibaud Mathis, MD1; Jean-Pierre Caujolle, MD2; Juliette Thariat, MD, PhD3
JAMA Ophthalmol. 2020;138(1):e190388. doi:10.1001/jamaophthalmol.2019.0388
Clinical Science
The TERT copy number gain is sensitive to telomerase inhibitors in human melanoma
Jinyu Yu ; Jiayi Yu ; Xiaowen Wu ; Qian Guo ; Ting Yin ; Zhiyuan Cheng ; Jie Dai ; Yan Kong ; Jun Guo
Clin Sci (Lond) (2020) CS20190890.
https://doi.org/10.1042/CS20190890
JAMA
Original Investigation
November 13, 2019
Age-Specific Incidence of Melanoma in the United States
Kelly G. Paulson, MD, PhD1,2,3; Deepti Gupta, MD4,5,6; Teresa S. Kim, MD3,7; et alJoshua R. Veatch, MD, PhD1,2,3; David R. Byrd, MD3,7; Shailender Bhatia, MD1,2,3; Katherine Wojcik, PhD1; Aude G. Chapuis, MD1,2,3; John A. Thompson, MD1,2,3; Margaret M. Madeleine, PhD, MPH8,9; Jennifer M. Gardner, MD3,5
JAMA Dermatol. 2020;156(1):57-64. doi:10.1001/jamadermatol.2019.3353
CANCER CELL
ARTICLE| VOLUME 37, ISSUE 1, P55-70.E15, JANUARY 13, 2020
Epigenetic Silencing of CDR1as Drives IGF2BP3-Mediated Melanoma Invasion and Metastasis
Douglas Hanniford, Alejandro Ulloa-Morales, Alcida Karz, Iman Osman, Iannis Aifantis, Eva Hernando, et al
DOI:https://doi.org/10.1016/j.ccell.2019.12.007
Cancer Cell
Volume 37, Issue 1, 13 January 2020, Pages 85-103.e9
Article
Myosin II Reactivation and Cytoskeletal Remodeling as a Hallmark and a Vulnerability in Melanoma Therapy Resistance
Author links open overlay panelJose L.Orgaz12EvaCrosas-Molist1210AmineSadok310AnnaPerdrix-Rosell12410OscarMaiques1210IreneRodriguez-Hernandez1210JoMonger1SilviaMele5MirellaGeorgouli2VictoriaBridgeman4PanagiotisKaragiannis56RebeccaLee7PahiniPandya2LenaBoehme2FredrikWallberg8ChrisTape9Sophia N.Karagiannis5IlariaMalanchi4VictoriaSanz-Moreno1211
Show more
https://doi.org/10.1016/j.ccell.2019.12.003
Nature
Helmink, B.A., Reddy, S.M., Gao, J. et al. B cells and tertiary lymphoid structures promote immunotherapy response. Nature (2020) doi:10.1038/s41586-019-1922-8
- Received05 February 2019
- Accepted04 December 2019
- Published15 January 2020
- DOI https://doi.org/10.1038/s41586-019-1922-8
The MITF-SOX10 regulated long non-coding RNA DIRC3 is a melanoma tumour suppressor
Elizabeth A. Coe, Jennifer Y. Tan, Michael Shapiro, Pakavarin Louphrasitthiphol, Andrew R. Bassett, Ana C. Marques, Colin R. Goding, Keith W. Vance
- Published: December 27, 2019
- https://doi.org/10.1371/journal.pgen.1008501
REVIEW
Open Access
Novel cancer therapies for advanced cutaneous melanoma: The added value of radiomics in the decision making process–A systematic review
Antonino Guerrisi, Emiliano Loi, Sara Ungania, Michelangelo Russillo, Vicente Bruzzaniti, Fulvia Elia, Flora Desiderio, Raffaella Marconi Francesco, Maria Solivetti, Lidia Strigari
First published: 17 January 2020 https://doi.org/10.1002/cam4.2709
Dove press
Does the Autophagy Related Gene 7 (ATG7) Have a Role in Non-Melanoma Skin Cancer?
Authors Samaka RM, Basha MA, Mansour E
Received 5 July 2019
Accepted for publication 29 November 2019
Published 20 January 2020 Volume 2020:13 Pages 49—58
DOI https://doi.org/10.2147/CCID.S222051